Search Ontology: 
        
        ChEBI
            semaxanib
- Term ID
- CHEBI:91083
- Synonyms
- 
    
        
        - (3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one
- (Z)-SU 5416
- 3-((Z)-(3,5-Dimethylpyrrol-2-yl)methylene)-2-indolinone
- 3-(1-(3,5-Dimethyl-1H-pyrrol-2-yl)meth-(Z)-ylidene)-2-oxo-2,3-dihydroindole
- 3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]-2-indolinone
- semaxanib
- SU 5416
- SU5416
- TSU 16
 
- Definition
- An oxindole that is 3-methyleneoxindole in which one of the hydrogens of the methylene group is replaced by a 3,5-dimethylpyrrol-2-yl group.
- References
- 
    
        
        
    
    - CAS:194413-58-6
- KEGG:D05819
- PDBeChem:X2M
- PMID:25391620
- PMID:25450973
- PMID:25521760
- PMID:25665868
- PMID:25886469
- PMID:26291195
- PMID:26314590
- PMID:26418615
- PMID:26421302
- PMID:26593399
- PMID:26727223
- PMID:26790474
- PMID:26804178
- PMID:26813102
- Reaxys:7995521
- Wikipedia:Semaxanib
 
- Ontology
- ChEBI ( EBI )
                
                    
                        Phenotype 
                    
                    
                
                
            
        
        
    
        
            
            
    
    
    
    
                
                    
                        Phenotype resulting from semaxanib
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Phenotype where environments contain semaxanib
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Phenotype modified by environments containing semaxanib
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Phenotype affecting semaxanib
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Human Disease Model
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    